AXTA vs the Top Picks average
| Pillar | AXTA | Book avg | Diff |
|---|---|---|---|
| Quality | 65 | 83 | -18 |
| Growth | 33 | 89 | -56 |
| Value | 68 | 76 | -8 |
Average of today's Top 30 (mean score 82.6); size and sector limits also decide the book.
One point per daily run; read From → To for the actual range.
AXTA at a glance
Same audited fundamentals as the score, unless a card says otherwise.
Analyst estimate revisions
| 30-day change | -0.0% |
|---|---|
| 90-day change | +1.7% |
| Forward EPS estimate | $2.86 |
Over the last 90 days, what analysts expect AXTA to earn is drifting higher (+1.7%). The estimate is derived from price and forward P/E captured at the same instant, so a moving share price does not move this number — only a changed forecast does.
Estimates move both ways and are not part of the Bull Rankings score. Biggest movers →
Math only: excludes commissions, slippage and gap risk. Inputs stay in your browser.
Axalta Coating Systems Ltd. (AXTA): score, valuation & FAQ
Axalta Coating Systems Ltd. (AXTA) is a Specialty Chemicals company that scores 52.5 out of 100 on the Bull Rankings quality-growth model — a middling reading. The score blends three pillars — quality (durable returns, healthy margins, low leverage), growth (revenue and earnings), and value (valuation versus sector peers) — into one number, refreshed daily; it is a screen, not a buy recommendation.
The model flags Rev (D+) as weaker areas. On valuation, AXTA sits about 10% above our discounted-cash-flow fair value — the current price implies free cash flow growing about 8% next year, slowing to 4% a year by year ten.
Is AXTA a good stock to buy?
Bull Rankings scores AXTA 52.5 out of 100 on its quality-growth model, which is a middling reading. A score is a quantitative screen of Axalta Coating Systems Ltd.'s fundamentals, not personalised financial advice — weigh it against your own time horizon and risk tolerance, and read the risk factors below before acting.
Why does AXTA score 52.5 on Bull Rankings?
The score leans on value at 67.5 out of 100, with growth the weakest pillar at 33.1 — the three combine geometrically, so a weak one cannot be papered over by a strong one. AXTA grades middle-of-pack across the graded signals, and is held back by Rev (D+). Each signal is graded against sector-aware thresholds rather than one absolute bar, so AXTA is measured against Specialty Chemicals peers, not against the market as a whole.
Is AXTA overvalued or undervalued?
Based on $32.63, AXTA sits about 10% above our discounted-cash-flow fair value — the current price implies free cash flow growing about 8% next year, slowing to 4% a year by year ten. It trades at a 20.0x P/E (graded B). Discounted-cash-flow estimates are sensitive to growth and discount-rate assumptions, so treat this as a cross-check, not a price target.
What are the main risks of investing in AXTA?
Mature compounder — the risk is paying up for quality at a moment when growth is decelerating. Watch for sequential revenue + margin trends; the inflection from "compounder" to "ex-compounder" is hard to spot until the multiple already started compressing.
New to these metrics? See the guides and the methodology.